Regenerative ophthalmology: Technologic and pharmacologic approaches to restoring sight via retinal prosthesis

R. Iezzi

Research output: Contribution to journalArticle

1 Scopus citations


Retinal prosthesis technology can restore rudimentary form vision in patients with retinitis pigmentosa (RP) who have lost all eyesight. This continually advancing field within regenerative ophthalmology represents the merger of micro-electromechanical systems technology with neurosensory retina. This man-machine interface is reliant upon the long-term health of a neurosensory retina undergoing progressive pathophysiologic changes. Pharmacologic approaches that address the pathophysiologic consequences of RP will likely play an important role for all regenerative treatment strategies.

Original languageEnglish (US)
Pages (from-to)33-35
Number of pages3
JournalClinical Pharmacology and Therapeutics
Issue number1
StatePublished - Jan 1 2016


ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this